Exploiting Arginine Auxotrophy with Pegylated Arginine Deiminase (ADI-PEG20) to Sensitize Pancreatic Cancer to Radiotherapy via Metabolic Dysregulation

Molecular Cancer Therapeutics
Pankaj Kumar SinghSunil Krishnan

Abstract

Distinct metabolic vulnerabilities of cancer cells compared with normal cells can potentially be exploited for therapeutic targeting. Deficiency of argininosuccinate synthetase-1 (ASS1) in pancreatic cancers creates auxotrophy for the semiessential amino acid arginine. We explored the therapeutic potential of depleting exogenous arginine via pegylated arginine deiminase (ADI-PEG20) treatment as an adjunct to radiotherapy. We evaluated the efficacy of treatment of human pancreatic cancer cell lines and xenografts with ADI-PEG20 and radiation via clonogenic assays and tumor growth delay experiments. We also investigated potential mechanisms of action using reverse-phase protein array, Western blotting, and IHC and immunofluorescence staining. ADI-PEG20 potently radiosensitized ASS1-deficient pancreatic cancer cells (MiaPaCa-2, Panc-1, AsPc-1, HPAC, and CaPan-1), but not ASS1-expressing cell lines (Bxpc3, L3.6pl, and SW1990). Reverse phase protein array studies confirmed increased expression of proteins related to endoplasmic reticulum (ER) stress and apoptosis, which were confirmed by Western blot analysis. Inhibition of ER stress signaling with 4-phenylbutyrate abrogated the expression of ER stress proteins and reversed radiosen...Continue Reading

References

Apr 12, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Frederick W HoltsbergMike A Clark
Jul 17, 2003·International Journal of Cancer. Journal International Du Cancer·Hong GongLothar Schweigerer
Aug 28, 2003·British Journal of Cancer·I-S ParkB-H Min
May 24, 2006·Biochimica Et Biophysica Acta·Yoshihide TsujimotoShigeomi Shimizu
Jul 29, 2008·International Journal of Cancer. Journal International Du Cancer·Tawnya L BowlesRichard J Bold
Jan 13, 2009·PloS One·Jonathan H LinPeter Walter
Mar 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christine A Iacobuzio-DonahueDaniel Laheru
Apr 30, 2010·The New England Journal of Medicine·Manuel Hidalgo
Jul 10, 2010·Radiation Oncology·Thomas B Brunner, Martin Scott-Brown
Jul 14, 2010·Translational Research : the Journal of Laboratory and Clinical Medicine·Lianshu DingZhen Fu
Oct 19, 2010·Chembiochem : a European Journal of Chemical Biology·Leilei ZhuUlrich Schwaneberg
Mar 3, 2011·Nature Cell Biology·Ira Tabas, David Ron
Jan 19, 2012·Nature Reviews. Molecular Cell Biology·Claudio Hetz
Jan 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Peter W SzlosarekNorbert Avril
Dec 17, 2014·Journal of Experimental & Clinical Cancer Research : CR·Rouzbeh DaylamiRichard J Bold
Feb 27, 2015·PloS One·Min YuRufu Chen
Mar 6, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin K TomlinsonPrimo N Lara
Jun 9, 2015·Frontiers in Cell and Developmental Biology·Sonam Parakh, Julie D Atkin
Feb 26, 2016·International Journal of Cancer. Journal International Du Cancer·Livingstone FultangFrancis Mussai
Sep 14, 2016·Seminars in Radiation Oncology·Awalpreet S ChadhaSunil Krishnan
Jan 6, 2017·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Apr 8, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Emma BeddowesPeter W Szlosarek
Jun 4, 2017·Surgical Oncology Clinics of North America·Shahed N BadiyanAdeel Kaiser
Jun 16, 2017·Molecular & Cellular Oncology·Jeff C Kremer, Brian A Van Tine

❮ Previous
Next ❯

Citations

Jan 5, 2021·Chinese Medical Journal·Jin-Shou YangLei You
Dec 9, 2020·ELife·Natalya N PavlovaCraig B Thompson
May 28, 2021·Frontiers in Oncology·Marike W van GisbergenLudwig J Dubois
Jul 25, 2021·Cancers·Chia-Lin ChenHsing-Jien Kung
Sep 18, 2021·Molecular Carcinogenesis·Carly S WilderJohn DiGiovanni
Nov 4, 2021·Expert Opinion on Investigational Drugs·Byung Woog Kang, Ian Chau
Nov 6, 2021·Science Advances·Rossella MarulloLeandro Cerchietti

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis